Related Experiment Videos
CD20-positive adult T-cell leukemia
M Yasukawa1, J Arai, M Kakimoto
1First Department of Internal Medicine, Ehime University School of Medicine, Shigenobu, Japan. yasukawa@m.ehime-u.ac.jp
American Journal of Hematology
|June 28, 2001
Summary
This study reports the first case of CD20-positive adult T-cell leukemia (ATL), a rare cancer. Human T-lymphotropic virus type I (HTLV-I) may infect and transform these unique CD20-positive T cells.
Area of Science:
- Hematology
- Oncology
- Virology
Background:
- Adult T-cell leukemia (ATL) is a lymphoproliferative malignancy.
- It is caused by infection with human T-lymphotropic virus type I (HTLV-I).
- T-cell associated antigens are typically expressed on ATL cells.
Observation:
- A 67-year-old woman presented with lymphadenopathy and lymphocytosis.
- Monoclonal integration of HTLV-I provirus DNA confirmed ATL diagnosis.
- Flow cytometry showed ATL cells expressed CD20 and T-cell antigens.
- CD20 mRNA expression was also detected in ATL cells.
Findings:
- This is the first documented case of CD20-positive ATL.
- A novel T-cell subpopulation expressing CD20 molecules has been identified.
- HTLV-I infection and transformation of CD20-positive T cells is suggested.
Implications:
- This finding expands the understanding of ATL heterogeneity.
- It suggests potential new therapeutic targets for CD20-positive ATL.
- Further research into HTLV-I's interaction with CD20-positive T cells is warranted.